品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
源叶 | S83807-5mg | 5mg | 厂家现货 | 164658-13-3 |
CGP60474 CGP60474 |
99% |
|
|
源叶 | S83807-10mg | 10mg | 厂家现货 | 164658-13-3 |
CGP60474 CGP60474 |
99% |
|
|
源叶 | S83806-50mg | 50mg | 厂家现货 | 164658-13-3 |
Efinaconazole Efinaconazole |
98% |
|
|
索莱宝 | YS143671-5mg | 5mg | 厂家现货 | 164658-13-3 |
3-((4-(2-((3-氯苯基)氨基)嘧啶-4-基)吡... Cgp-60474 |
98% |
|
|
索莱宝 | YS143671-10mg | 10mg | 厂家现货 | 164658-13-3 |
3-((4-(2-((3-氯苯基)氨基)嘧啶-4-基)吡... Cgp-60474 |
98% |
|
|
索莱宝 | YS143671-50mg | 50mg | 厂家现货 | 164658-13-3 |
3-((4-(2-((3-氯苯基)氨基)嘧啶-4-基)吡... Cgp-60474 |
98% |
|
|
索莱宝 | YS143671-250mg | 250mg | 厂家现货 | 164658-13-3 |
3-((4-(2-((3-氯苯基)氨基)嘧啶-4-基)吡... Cgp-60474 |
98% |
|
|
索莱宝 | YS143671-100mg | 100mg | 厂家现货 | 164658-13-3 |
3-((4-(2-((3-氯苯基)氨基)嘧啶-4-基)吡... Cgp-60474 |
98% |
|
|
索莱宝 | YS143671-25mg | 25mg | 厂家现货 | 164658-13-3 |
3-((4-(2-((3-氯苯基)氨基)嘧啶-4-基)吡... Cgp-60474 |
98% |
|
|
阿拉丁 | C125354-10mg | 10mg | 现货 | 164658-13-3 |
CGP60474,CDK抑制剂 CGP60474 |
≥99% |
|
|
阿拉丁 | C125354-25mg | 25mg | 现货 | 164658-13-3 |
CGP60474,CDK抑制剂 CGP60474 |
≥99% |
|
|
阿拉丁 | C125354-100mg | 100mg | 现货 | 164658-13-3 |
CGP60474,CDK抑制剂 CGP60474 |
≥99% |
|
|
阿拉丁 | C125354-50mg | 50mg | 现货 | 164658-13-3 |
CGP60474,CDK抑制剂 CGP60474 |
≥99% |
|
|
阿拉丁 | C125354-5mg | 5mg | 现货 | 164658-13-3 |
CGP60474,CDK抑制剂 CGP60474 |
≥99% |
|
|
麦克林 | C881636-5mg | 5mg | 厂家现货 | 164658-13-3 |
CGP60474 CGP60474 |
≥99% |
|
|
麦克林 | C881636-10mg | 10mg | 厂家现货 | 164658-13-3 |
CGP60474 CGP60474 |
≥99% |
|
|
毕得 | BD630418-10mg | 10mg | 现货 | 164658-13-3 |
3-((4-(2-((3-氯苯基)氨基)嘧啶-4-基)吡... 3-((4-(2-((3-Chlorophenyl)am... |
98% |
|
|
毕得 | BD630418-50mg | 50mg | 现货 | 164658-13-3 |
3-((4-(2-((3-氯苯基)氨基)嘧啶-4-基)吡... 3-((4-(2-((3-Chlorophenyl)am... |
98% |
|
|
毕得 | BD630418-100mg | 100mg | 现货 | 164658-13-3 |
3-((4-(2-((3-氯苯基)氨基)嘧啶-4-基)吡... 3-((4-(2-((3-Chlorophenyl)am... |
98% |
|
|
毕得 | BD630418-5mg | 5mg | 现货 | 164658-13-3 |
3-((4-(2-((3-氯苯基)氨基)嘧啶-4-基)吡... 3-((4-(2-((3-Chlorophenyl)am... |
98% |
|
|